Tower Research Capital LLC (Trc) Amicus Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,189 shares of FOLD stock, worth $109,540. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,189

Previous 57,673 80.6%

Holding current value

$109,540

Previous $572,000 79.2%

% of portfolio

0.0%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $443,922 - $561,991	-46,484 Reduced 80.6%	11,189 $119,000
Q2 2024 Aug 13, 2024	BUY	$9.04 - $11.75 $500,996 - $651,185	55,420 Added 2459.83%	57,673 $572,000
Q1 2024 May 15, 2024	SELL	$11.43 - $14.24 $280,023 - $348,865	-24,499 Reduced 91.58%	2,253 $26,000
Q4 2023 Feb 13, 2024	BUY	$9.97 - $14.52 $44,974 - $65,499	4,511 Added 20.28%	26,752 $379,000
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $114,266 - $134,442	9,700 Added 77.35%	22,241 $270,000
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $73,314 - $90,958	-6,839 Reduced 35.29%	12,541 $157,000
Q1 2023 May 09, 2023	BUY	$10.91 - $13.54 $178,924 - $222,056	16,400 Added 550.34%	19,380 $215,000
Q4 2022 Feb 10, 2023	SELL	$9.89 - $12.7 $842,914 - $1.08 Million	-85,229 Reduced 96.62%	2,980 $37,000
Q3 2022 Nov 10, 2022	BUY	$9.82 - $12.75 $396,914 - $515,342	40,419 Added 84.58%	88,209 $921,000
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $71,694 - $127,968	11,508 Added 31.72%	47,790 $514,000
Q1 2022 May 12, 2022	BUY	$7.89 - $12.48 $118,618 - $187,624	15,034 Added 70.75%	36,282 $343,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $244,763 - $310,067	-24,925 Reduced 53.98%	21,248 $245,000
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $225,430 - $305,389	25,793 Added 126.56%	46,173 $441,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $77,893 - $95,868	-8,943 Reduced 30.5%	20,380 $197,000
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $36,938 - $95,797	4,015 Added 15.86%	29,323 $289,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $225,568 - $416,807	16,746 Added 195.59%	25,308 $584,000
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $243,131 - $299,717	-18,862 Reduced 68.78%	8,562 $121,000
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $242,976 - $430,282	27,424 New	27,424 $414,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $81,853 - $137,781	-12,346 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$7.48 - $10.75 $91,600 - $131,644	12,246 Added 12246.0%	12,346 $120,000
Q3 2019 Nov 05, 2019	BUY	$8.02 - $13.25 $802 - $1,325	100 New	100 $1,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $110,548 - $177,300	-13,192 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $153,027 - $218,195	13,192 New	13,192 $159,000
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $12,989 - $16,161	-944 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$12.51 - $16.24 $61,724 - $80,128	-4,934 Reduced 83.94%	944 $14,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $69,007 - $92,754	5,878	5,878 $89,000

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Amicus Therapeutics, Inc. Transaction History